Jump to content
RemedySpot.com

Resveratrol Studies

Rate this topic


Guest guest

Recommended Posts

Fungicidal effect of resveratrol on human infectious fungi.

Arch Pharm Res. 2005 May;28(5):557-60.

Resveratrol, a phenolic antioxidant found in grapes, has been known

to mediate various biological activities on the human body. In the

present study, we tested the antifungal activity of resveratrol

against human pathogenic fungi before carrying out further studies to

elucidate the antifungal mechanism(s) of resveratrol. Resveratrol

displayed potent antifungal activity against human pathogenic fungi

at concentration levels of 10-20 microg/mL. Furthermore, time-kill

curve exhibited fungicidal effect of resveratrol on Candida albicans,

but the compound had no hemolytic activity against human

erythrocytes. The destruction of C. albicans cells by resveratrol was

confirmed by scanning electron microscopy. These results suggest that

resveratrol could be employed as a therapeutic agent to treat fungal

infections of humans.

Resveratrol, a chemical found in red grapes, blocks replication of

the influenza virus in cell culture and in animals. In cell culture

experiments, resveratrol prevented influenza from replicating.

Resveratrol treatment had the greatest effect when administered 3

hours after exposure to influenza. Smaller but significant effects

were seen when treatment began 6 hours after infection, but at 9

hours after infection resveratrol treatment had no effect. Pre-

treatment also did not change susceptibility to infection. Studies in

a mouse model of influenza showed that injections of resveratrol

after inoculation of influenza increased survival by 40% compared

with placebo injections. The amount of virus present in the lung 6

days after infection was 98% lower in the resveratrol -treated mice.

Resveratrol's anti-influenza activity seems to center on its ability

to interfere with key " host-cell functions " that are essential for

virus replication, the authors explain in The Journal of Infectious

Diseases, May 15, 2005.

------------------------------

Resveratrol reduces oxidation and proliferation of human retinal

pigment epithelial cells via extracellular signal-regulated kinase

inhibition.

Chem Biol Interact. 2005 Jan 15;151(2):143-9. King RE, Kent KD,

Bomser JA.

Department of Food Science and Technology, Ohio State University,

Columbus, OH

Epidemiological evidence suggests that moderate wine consumption and

antioxidant-rich diets may protect against age-related macular

degeneration, the leading cause of vision loss among the elderly.

Development of age-related macular degeneration and other retinal

diseases, such as proliferative vitreoretinopathy (PVR), is

associated with oxidative stress in the retinal pigment epithelium

(RPE), a cell layer responsible for maintaining the health of the

retina by providing structural and nutritional support. We

hypothesize that resveratrol, a red wine polyphenol, may be

responsible, in part, for the health benefits of moderate red wine

consumption on retinal disease. To test this hypothesis, the

antioxidant and antiproliferative effects of resveratrol were

examined in a human RPE cell line (designated ARPE-19). These results

suggest that resveratrol can reduce oxidative stress and

hyperproliferation of the RPE.

-----------------------------------

Role of resveratrol in prevention and therapy of cancer: preclinical

and clinical studies.

Anticancer Res. 2004 Sep-Oct;24(5A):2783-840. Aggarwal BB, Bhardwaj

A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y.

Cytokine Research Laboratory, Department of Bioimmunotherapy, The

University of Texas M. D.

Besides cardioprotective effects, resveratrol exhibits anticancer

properties, as suggested by its ability to suppress proliferation of

a wide variety of tumor cells, including lymphoid and myeloid

cancers; multiple myeloma; cancers of the breast, prostate, stomach,

colon, pancreas, and thyroid; melanoma; head and neck squamous cell

carcinoma; ovarian carcinoma; and cervical carcinoma. The growth-

inhibitory effects of resveratrol are mediated through cell-cycle

arrest; upregulation of p21Cip1/WAF1, p53 and Bax; down-regulation of

survivin, cyclin D1, cyclin E, Bcl-2, Bcl-xL and clAPs; and

activation of caspases. Resveratrol has been shown to suppress the

activation of several transcription factors, including NF-kappaB, AP-

1 and Egr-1; to inhibit protein kinases including IkappaBalpha

kinase, JNK, MAPK, Akt, PKC, PKD and casein kinase II; and to down-

regulate products of genes such as COX-2, 5-LOX, VEGF, IL-1, IL-6, IL-

8, AR and PSA. These activities account for the suppression of

angiogenesis by this stilbene. Resveratrol also has been shown to

potentiate the apoptotic effects of cytokines (e.g., TRAIL),

chemotherapeutic agents and gamma-radiation. Phamacokinetic studies

revealed that the target organs of resveratrol are liver and kidney,

where it is concentrated after absorption and is mainly converted to

a sulfated form and a glucuronide conjugate. In vivo, resveratrol

blocks the multistep process of carcinogenesis at various stages: it

blocks carcinogen activation by inhibiting aryl hydrocarbon-induced

CYP1A1 expression and activity, and suppresses tumor initiation,

promotion and progression. Besides chemopreventive effects,

resveratrol appears to exhibit therapeutic effects against cancer.

Limited data in humans have revealed that resveratrol is

pharmacologically quite safe. Currently, structural analogues of

resveratrol with improved bioavailability are being pursued as

potential therapeutic agents for cancer.

Consumption of red wine is associated with a slight but statistically

significant reduction in the development of lung cancer, as reported

in the journal Thorax. Red wine contains tannins and resveratrol,

substances which could explain the drink's anti-cancer properties.

Tannins act as antioxidants, which mop up free radicals — particles

harmful to cells. Resveratrol is known to fight cancer tumor growth.

-------------------

Resveratrol-induced cellular apoptosis and cell cycle arrest in

neuroblastoma cells and antitumor effects on neuroblastoma in mice.

Surgery. 2004 Jul;136(1):57-66.

The prognosis of neuroblastoma patients remains unsatisfactory.

Therefore, developing an effective treatment strategy is important.

Resveratrol, a natural polyphenol, possesses chemopreventive and

antitumor effects. We investigated the effects of resveratrol on the

proliferation, apoptosis, and cell cycle alteration of neuroblastoma

cells and determined its effects on neuroblastoma tumors in mice.

METHODS: Cytotoxic effects, cellular apoptosis, and alterations in

the cell cycle were determined in neuro-2a neuroblastoma cells

exposed for varying lengths of time to a series of resveratrol

concentrations. Expression of associated cell cycle regulatory

proteins, cyclin E and p21, was detected by Western blot analysis,

and the antitumor effects of resveratrol were investigated by

treating subcutaneous neuroblastoma tumors with intraperitoneal

injections of 40 mg/kg resveratrol daily for 28 days. RESULTS:

Resveratrol exerted cytotoxic effects on neuroblastoma cells. After

resveratrol treatment, the apoptosis rate of the neuroblastoma cells

significantly increased, a significant accumulation of cells occurred

at the S phase of the cell cycle, p21 was downregulated, and cyclin E

was upregulated. In addition, resveratrol treatment suppressed the

growth rate of subcutaneous neuroblastomas, resulting in 70% long-

term survival. CONCLUSION: Resveratrol caused significant

cytotoxicity and increased apoptosis and S-phase accumulation of

neuroblastoma cells. S-phase accumulation was related to the down-

regulation of p21 and up-regulation of cyclin E. In addition,

resveratrol exerted antitumor effects on neuroblastomas in mice.

Thus, resveratrol shows promise for the treatment of neuroblastoma.

------------------

Anti-inflammatory Effects of Resveratrol in Lung Epithelial Cells:

Molecular Mechanisms.

Am J Physiol Lung Cell Mol Physiol. 2004 Jun 4

Resveratrol is a polyphenolic stilbene found in the skins of red

fruits including grapes that may be responsible for some of the

health benefits ascribed to the consumption of red wine. Resveratrol

has previously been shown to have anti-oxidant properties and can act

as an estrogen agonist. This study examined the anti-inflammatory

effects of resveratrol on human airway epithelial cells. Resveratrol

and the related molecule quercetin, but not deoxyrhapontin, inhibited

both interleukin (IL)-8 and granulocyte-macrophage colony stimulating

factor (GM-CSF) release from A549 cells. Neither the estrogen

receptor antagonist, tamoxifen, nor the glucocorticoid antagonist,

mifepristone, altered the inhibitory effect of resveratrol. The

mechanism of resveratrol action was investigated further using

luciferase reporter genes stably transfected into A549 cells. Both

resveratrol and quercetin inhibited NF-kappaB-, AP-1- and CREB-

dependent transcription to a greater extent than the

glucocorticosteroid, dexamethasone. These compounds also had no

significant effect on acetylation or deacetylation of core histones.

Resveratrol, but not estradiol or N-acetyl cysteine, inhibited

cytokine-stimulated inducible nitric oxide synthase expression and

nitrite production in human primary airway epithelial cells.

Resveratrol also inhibited GM-CSF release, IL-8 release and cyclo-

oxygenase-2 expression in these cells. This study demonstrates that

resveratrol and quercetin have novel non-steroidal anti-inflammatory

activity that may have applications for the treatment of inflammatory

diseases.

----------------------

Identification of a p53-dependent pathway in the induction of

apoptosis of human breast cancer cells by the natural product,

resveratrol.

Laux MT, Aregullin M, College of Veterinary Medicine, Cornell

University, Ithaca, NY, USA.

J Altern Complement Med. 2004 Apr;10(2):235-9.

Resveratrol, a constituent found in grapes and various other plants,

has been shown to have chemo-preventive activity against cancer, and

specifically demonstrated to induce apoptosis by p53-dependent

pathways in murine cells. DESIGN: A number of human breast cancer

cell lines, as well as a control of a wild-type line (astrocytoma N

1321N1), were investigated for induction of apoptosis by resveratrol

using both microscopic evaluation and DNA fragmentation assays.

RESULTS: Apoptosis induced by resveratrol was found to occur only in

breast cancer cells expressing wild-type p53 but not in mutant p53-

expressing cells. CONCLUSIONS: We therefore conclude that the natural

product, resveratrol, induces apoptosis in breast cancer cells via

p53-dependent pathways.

--------------------

Curcumin and resveratrol induce apoptosis and nuclear translocation

and activation of p53 in human neuroblastoma.

Anticancer Res. 2004 Mar-Apr;24(2B):987-98.

BACKGROUND: Neuroblastoma (NB) is an aggressive childhood cancer of

the peripheral nervous system arising from neural crest

sympathoadrenal progenitor cells. Despite current rigorous treatment

protocols, prognosis for high stage NB patients is poor and so there

remains a need for more effective, less cytotoxic treatments.

Curcumin and resveratrol possess anti-tumor properties in adult

cancer models and negligible toxicity in normal cells, but little is

known about the effect of these agents on pediatric cancers.

MATERIALS AND METHODS: Stage 4 MYCN-amplified NB cell lines, with

wild-type or mutant p53, were treated with curcumin and resveratrol

and analyzed for effects on proliferation, cell cycle, induction of

apoptosis and p53 function. RESULTS: Treatment with resveratrol and

curcumin induced a dose- and time-dependent decrease in cell

viability, cell cycle arrest and induction of apoptosis. CONCLUSION:

Observations suggest that the cytotoxicity, cell cycle arrest and

apoptosis induced by curcumin and resveratrol in NB cells may be

mediated via functionally activated p53 and merit further study.

-----------------------

Resveratrol in raw and baked blueberries and bilberries.

J Agric Food Chem. 2003 Sep 24;51(20):5867-70.

Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J, van Breemen RB.

Food and Nutritional Science Division, California State University-

Long Beach, CA 90840

Resveratrol in the fruits of bilberry (Vaccinium myrtillus L.), the

lowbush " wild " blueberry (Vaccinium angustifolium Aiton), the

rabbiteye blueberry (Vaccinium ashei Reade), and the highbush

blueberry (Vaccinium corymbosum L.) were measured using a new assay

based on high-performance liquid chromatography-tandem mass

spectrometry (LC-MS/MS). The LC-MS/MS assay provided lower limits of

detection than previous methods for resveratrol measurement, 90 fmol

of trans-resveratrol injected on-column, and a linear standard curve

spanning >3 orders of magnitude. The recoveries of resveratrol from

blueberries spiked with 1.8, 3.6, or 36 ng/g were 91.5 +/- 4.5, 95.6

+/- 6.5, and 88.0 +/- 3.6%, respectively. trans-Resveratrol but not

cis-resveratrol was detected in both blueberry and bilberry samples.

The highest levels of trans-resvertatrol in these specimens were

140.0 +/- 29.9 pmol/g in highbush blueberries from Michigan and 71.0

+/- 15.0 pmol/g in bilberries from Poland. However, considerable

regional variation was observed; highbush blueberries from British

Columbia contained no detectable resveratrol. Because blueberries and

bilberries are often consumed after cooking, the effect of baking on

resveratrol content was investigated. After 18 min of heating at 190

degrees C, between 17 and 46% of the resveratrol had degraded in the

various Vaccinium species. Therefore, the resveratrol content of

baked or heat-processed blueberries or bilberries should be expected

to be lower than in the raw fruit. Although blueberries and

bilberries were found to contain resveratrol, the level of this

chemoprotective compound in these fruits was <10% that reported for

grapes. Furthermore, cooking or heat processing of these berries will

contribute to the degradation of resveratrol.

--------------------

Wine and tumors: study of resveratrol.

Drugs Exp Clin Res. 2003;29(5-6):257-61.

In modern industrial societies the attention to public health,

especially in relation to food habits, is increasing day by day.

Considering this, it's no wonder that wine, the voluptuary drink that

best represents human history, is the most interesting compound. The

main and best known wine effects on the human body are caused by

alcohol, but several other active compounds are present in wine.

Above all, resveratrol is able to neutralize free radicals, which can

damage DNA and may lead to cancer onset. In this study, we have

indagated resveratrol anticancer action, analyzing its effects on

both cell cycle and growing of human lymphoma B (DHL-4) cells. MTT

colorimetric test, tripan blue dye exclusion assay, and cell cycle

analysis showed that resveratrol has a dose-dependent

antiproliferative and antiapoptotic action on DHL-4 cells. These

results confirm resveratrol's potential therapeutic role on tumors.

---------------------------

Potent induction of cellular antioxidants and phase 2 enzymes by

resveratrol in cardiomyocytes: protection against oxidative and

electrophilic injury.

Cao Z, Li Y. St. 's University College of Pharmacy and Allied

Health Professions, Jamaica, NY

Eur J Pharmacol. 2004 Apr 5;489(1-2):39-48.

Resveratrol is known to be protective against oxidative

cardiovascular disorders. However, the underlying mechanisms remain

unclear. This study was undertaken to determine if resveratrol could

increase endogenous antioxidants and phase 2 enzymes in

cardiomyocytes, and if such increased cellular defenses could provide

protection against oxidative and electrophilic cell injury.

Incubation of cardiac H9C2 cells with low micromolar resveratrol

resulted in a significant induction of a scope of cellular

antioxidants and phase 2 enzymes in a concentration- and/or time-

dependent fashion. To investigate the protective effects of the

resveratrol-induced cellular defenses on oxidative and electrophilic

cell injury, H9C2 cells were first incubated with resveratrol, and

then exposed to xanthine oxidase (XO)/xanthine, 4-hydroxy-2-nonenal

or doxorubicin. We observed that resveratrol pretreatment afforded a

marked protection against the above agent-mediated cytotoxicity in

H9C2 cells. Moreover, the resveratrol pretreatment led to a great

reduction in XO/xanthine-induced intracellular accumulation of ROS.

Taken together, this study demonstrates that resveratrol induces

antioxidants and phase 2 enzymes in cardiomyocytes, which is

accompanied by increased resistance to oxidative and electrophilic

cell injury.

---------------------

Modulation of androgen receptor-dependent transcription by

resveratrol and genistein in prostate cancer cells.

Gao S, Liu GZ, Wang Z.

The University of Texas M. D. Cancer Center, Houston, Texas.

Prostate. 2004 May 1;59(2):214-25.

BACKGROUND: The androgen receptor (AR) is a ligand-activated

transcription factor that mediates the biological responses of

androgens in the prostate gland. This study focuses on the

chemopreventive agents, resveratrol and genistein, on AR-mediated

transcription in prostate cancer cells. RESULTS: We found that

resveratrol and genistein activated AR-driven gene expression at low

concentrations, whereas they repressed the AR-dependent reporter gene

activity at high concentrations. We determined that resveratrol and

genistein induced AR-driven gene expression by activating the Raf-MEK-

ERK kinase pathway. The ERK1 kinase phosphorylated the AR on multiple

sites in vitro, but this phosphorylation event did not contribute to

the resveratrol-induced AR transactivation. CONCLUSIONS: In vitro and

in vivo studies have indicated that resveratrol and genistein are

promising chemopreventive agents. Given the clear evidence that AR

pathways are involved in the development and progression of prostate

cancer, these data showed that the ability to modulate AR function

would contribute the observed chemopreventive activity of resveratrol

and genistein.

-------------------

Resveratrol suppresses the angiogenesis and tumor growth of gliomas

in rats.

Clin Cancer Res. 2004 Mar 15;10(6):2190-202.

PURPOSE: We wanted to investigate the antitumor effects and effect on

angiogenesis of resveratrol in rat RT-2 gliomas. RT-2 glioma cells

were treated with resveratrol, and then cytotoxicity was assayed,

apoptosis was measured by flow-activated cell sorter flow cytometry,

and expression of vascular endothelial growth factor was measured by

reverse transcription-PCR. Tumor size, animal survival time, and

survival rate were followed in resveratrol-treated rats with s.c. or

intracerebral gliomas. Furthermore, in vitro proliferation was

assayed to explore the effect of resveratrol on the proliferation of

ECV304 human umbilical vein endothelial cells. Expression of CD31 in

resveratrol-treated gliomas was followed immunohistochemically to

study the effect of resveratrol on the glioma-induced angiogenesis.

RESULTS: Resveratrol was demonstrated to exert cytotoxic effects and

induce glioma cell apoptosis in a concentration- and time-dependent

manner. Resveratrol (40 mg/kg/day) exerted significant antitumor

effects on s.c. tumors, including slower tumor growth rate, longer

animal survival time, and higher animal survival rate (P < 0.05). In

contrast, resveratrol affected intracerebral tumors at only an

increased dose (100 mg/kg/day), prolonging animal survival (P < 0.05)

without affecting survival rate. The expression of vascular

endothelial growth factor in the glioma cells and the proliferation

of ECV304 cells were inhibited by resveratrol in a concentration-

dependent manner. Immunohistochemical analyses showed that the s.c.

gliomas from resveratrol-treated rats had fewer microvessel densities

than did control rats. CONCLUSIONS: Resveratrol caused significant

glioma cell cytotoxicity and apoptosis, exerted antitumor effects on

the s.c. and intracerebral gliomas, and inhibited angiogenesis in

s.c. gliomas. Thus, resveratrol might be considered a possible

treatment strategy for gliomas.

------------------

Neuroprotective effects of resveratrol against beta-amyloid-induced

neurotoxicity in rat hippocampal neurons: involvement of protein

kinase C.

Br J Pharmacol. 2004 Mar;141(6):997-1005.

Resveratrol, an active ingredient of red wine extracts, has been

shown to exhibit neuroprotective effects in several experimental

models. The present study evaluated the neuroprotective effects of

resveratrol against amyloid beta(Abeta)-induced toxicity in cultured

rat hippocampal cells and examined the role of the protein kinase C

(PKC) pathway in this effect. Pre-, co- and post-treatment with

resveratrol significantly attenuated Abeta-induced cell death in a

concentration-dependent manner. Taken together, the present results

indicate that PKC is involved in the neuroprotective action of

resveratrol against Abeta-induced toxicity.

-----------------

Resveratrol in raw and baked blueberries and bilberries.

J Agric Food Chem. 2003 Sep 24;51(20):5867-70.

Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J, van Breemen RB.

Food and Nutritional Science Division, California State University-

Long Beach, CA 90840

Resveratrol in the fruits of bilberry (Vaccinium myrtillus L.), the

lowbush " wild " blueberry (Vaccinium angustifolium Aiton), the

rabbiteye blueberry (Vaccinium ashei Reade), and the highbush

blueberry (Vaccinium corymbosum L.) were measured using a new assay

based on high-performance liquid chromatography-tandem mass

spectrometry (LC-MS/MS). The LC-MS/MS assay provided lower limits of

detection than previous methods for resveratrol measurement, 90 fmol

of trans-resveratrol injected on-column, and a linear standard curve

spanning >3 orders of magnitude. The recoveries of resveratrol from

blueberries spiked with 1.8, 3.6, or 36 ng/g were 91.5, 95.6 +/- 6.5,

and 88.0, respectively. trans-Resveratrol but not cis-resveratrol was

detected in both blueberry and bilberry samples. The highest levels

of trans-resvertatrol in these specimens were 140.0 +/- 29.9 pmol/g

in highbush blueberries from Michigan and 71.0 +/- 15.0 pmol/g in

bilberries from Poland. However, considerable regional variation was

observed; highbush blueberries from British Columbia contained no

detectable resveratrol. Because blueberries and bilberries are often

consumed after cooking, the effect of baking on resveratrol content

was investigated. After 18 min of heating at 190 degrees C, between

17 and 46% of the resveratrol had degraded in the various Vaccinium

species. Therefore, the resveratrol content of baked or heat-

processed blueberries or bilberries should be expected to be lower

than in the raw fruit. Although blueberries and bilberries were found

to contain resveratrol, the level of this chemoprotective compound in

these fruits was <10% that reported for grapes. Furthermore, cooking

or heat processing of these berries will contribute to the

degradation of resveratrol.

----------------

Resveratrol protects myocardial ischemia-reperfusion injury through

both NO-dependent and NO-independent mechanisms.

Free Radic Biol Med. 2004 Mar 15;36(6):774-81.

We previously showed that resveratrol (3,4',5-trihydroxystilbene)

stimulates NO production and is cardioprotective in rat heart

subjected to ischemia-reperfusion (I/R rat heart). We now show that

in I/R rat heart, inducible nitric oxide synthase (iNOS) expression

is markedly induced, while expression of endothelial nitric oxide

synthase (eNOS) and nueronal nitric oxide synthase (nNOS) is

unchanged. In animals preconditioned with resveratrol (0.5 to 1 mg/kg

body wt), I/R-induced iNOS induction is abrogated; however,

expression of eNOS and nNOS is greatly upregulated. The protective

effects of resveratrol on I/R rat heart include reduced rhythm

disturbances, reduced cardiac infarct size, and decreased plasma

levels of lactate dehydrogenase (LDH) and creatine kinase (CK). Among

these, the reductions in LDH/CK levels and infarct size are NO-

dependent as the coadministration of N(omega)-nitro-L-arginine methyl

ester (L-NAME, 1 mg/kg body wt) with resveratrol abolishes the

resveratrol effect. In contrast, the reductions in the severity of

ventricular arrhythmia and mortality rate are not affected by L-NAME

coadministration, suggesting that a NO-independent mechanism is

involved.

(From: http://www.raysahelian.com/resveratrol.html)

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...